Alendronate
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Synonyms / Brand Names: Acide Alendronique, Acido Alendronico, Acidum Alendronicum, Alendronate Sodium, Alendronic acid, Adronat, Alendros, Arendal, Fosamax, Onclast
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753
Dosing and Administration
FOSAMAX must be taken at least one-half hour before the first food, beverage, or
medication of the day with plain water only. Other beverages (including mineral water), food, and some medications
are likely to reduce the absorption of FOSAMAX . Waiting less than 30 minutes, or taking FOSAMAX with food, beverages
(other than plain water) or other medications will lessen the effect of FOSAMAX by
decreasing its absorption into the body.
To facilitate delivery to the stomach and thus reduce the potential for esophageal
irritation, FOSAMAX should only be swallowed upon arising for the day with a full
glass of water (6-8 oz) and patients should not lie down for at least 30 minutes and
until after their first food of the day. FOSAMAX should not be taken at bedtime or
before arising for the day. Failure to follow these instructions may increase the risk
of esophageal adverse experiences
For more information on Dosing, please refer to Instructions for administration
FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.
Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.
Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.
Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information
Trial Resources
Ongoing Trials, Trial Results
Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.
Media Resources
Slides, Video, Images, MP3, Podcasts, etc.
Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.
International Resources
en Español
FDA Package Insert Resources
Indications
Contraindications
Side Effects
Drug Interactions
Precautions
Overdose
Instructions for Administration
How Supplied
Pharmacokinetics and Molecular Data
FDA label
FDA on Alendronate
Return to top
Publication Resources
Most Recent Articles on Alendronate
Review Articles on Alendronate
Articles on Alendronate in N Eng J Med, Lancet, BMJ
WikiDoc State of the Art Review
Textbook Information on Alendronate
Return to top
Trial Resources
Ongoing Trials with Alendronate at Clinical Trials.gov
Trial Results with Alendronate
Return to top
Guidelines & Evidence Based Medicine Resources
US National Guidelines Clearinghouse on Alendronate
Cochrane Collaboration on Alendronate
Cost Effectiveness of Alendronate
Return to top
Media Resources
Powerpoint Slides on Alendronate
Images of Alendronate
Podcasts & MP3s on Alendronate
Videos on Alendronate
Return to top
Patient Resources
Patient Information from National Library of Medicine
Patient Resources on Alendronate
Discussion Groups on Alendronate
Patient Handouts on Alendronate
Blogs on Alendronate
Alendronate in the News
Alendronate in the Marketplace
Return to top
International Resources
Alendronate en Español
Return to top
The content of this page is taken from the FDA package insert for this drug and should not be edited.
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
